Dermapharm Holding SE/ DE000A2GS5D8 /
| 08/11/2024 17:27:08 | Chg. +0.40 | Volume | Bid17:30:00 | Ask17:30:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 31.55EUR | +1.28% | 3,525 Turnover: 56,696.50 |
-Bid Size: - | -Ask Size: - | 1.66 bill.EUR | 2.85% | 26.59 |
Assets
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 56 | 80.9000 | 132.6000 | 199.6000 | 222.3000 | ||||||
| Intangible Assets | 133.4000 | 189.9000 | 293 | 297.3000 | 294.8000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 81.7000 | 117 | 175.6000 | 205.7000 | 243.6000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 6.3000 | 212.5000 | 115 | 120.3000 | 161.4000 | ||||||
| Current Assets | 192.9000 | 371.2000 | 352.9000 | 400.1000 | 519.2000 | ||||||
| Total Assets | 415.3000 | 704.6000 | 1,044.9000 | 1,224.4000 | 1,407 | ||||||
Liabilities
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 23.4000 | 28.2000 | 35.4000 | 50.4000 | 52.1000 | ||||||
| Long-term debt | 227 | 236.1000 | 562 | 581.1000 | 574.7000 | ||||||
| Liabilities to Banks | 264.9000 | 307.7000 | 580.4000 | 607.1000 | 581.1000 | ||||||
| Provisions | 21.3000 | 36.1000 | 49.1000 | 62.6000 | 103.6000 | ||||||
| Liabilities | 341.6000 | 448.5000 | 760.4000 | 899.8000 | 907.1000 | ||||||
| Share Capital | .1200 | 53.8400 | 53.8400 | 53.8400 | 53.8400 | ||||||
| Total Equity | 73.7000 | 256.1000 | 284.5000 | 324.6000 | 499.8000 | ||||||
| Minority Interests | 49.9000 | 3.6000 | 5.8000 | 2.6000 | 2.5000 | ||||||
| Total liabilities equity | 415.3000 | 704.6000 | 1,044.9000 | 1,224.4000 | 1,407 | ||||||
Income Statement
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 467.1000 | 572.4000 | 701 | 793.8000 | 942.9000 | ||||||
| Depreciation (total) | 16.5000 | 30.3000 | 50.1000 | 49.2000 | 55.6000 | ||||||
| Operating Result | 92.1000 | 107.5000 | 119.5000 | 136.9000 | 298.5000 | ||||||
| Interest Income | -5.7000 | -5.1000 | -8.4000 | -10 | -5.8000 | ||||||
| Income Before Taxes | 145.1000 | 104.2000 | 110.1000 | 125.3000 | 293 | ||||||
| Income Taxes | 10.3000 | 29 | 32.3000 | 39.4000 | 84.1000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 20.6000 | 75.2000 | 77.8000 | 85.9000 | 208.9000 | ||||||
Per Share
Cash Flow
|
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 86.7000 | 159.1000 | 100.6000 | 131.1000 | 250.4000 | ||||||
| Cash Flow from Investing Activities | -84.9000 | -110 | -382.2000 | -105.9000 | -129.3000 | ||||||
| Cash Flow from Financing | -8 | 164.4000 | 184 | -14.1000 | -81 | ||||||
| Decrease / Increase in Cash | -6.1000 | 213.6000 | -97.6000 | 11.1000 | 40 | ||||||
| Employees | 1,240 | 1,619 | 1,853 | 2,311 | 2,373 | ||||||
